VIR logo

VIR
Vir Biotechnology Inc

6,342
Mkt Cap
$901.53M
Volume
807,115.00
52W High
$14.45
52W Low
$4.16
PE Ratio
-1.79
VIR Fundamentals
Price
$6.13
Prev Close
$6.48
Open
$6.51
50D MA
$5.97
Beta
1.52
Avg. Volume
1.5M
EPS (Annual)
-$3.83
P/B
1.13
Rev/Employee
$181,875.00
Loading...
Loading...
News
all
press releases
Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an...
Business Wire·20h ago
News Placeholder
More News
News Placeholder
12,916,663 Shares in Vir Biotechnology, Inc. $VIR Bought by ARCH Venture Management LLC
ARCH Venture Management LLC purchased a new position in shares of Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) during the 2nd quarter, according to the company in its most recent filing with...
MarketBeat·4d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Shares Gap Up - Should You Buy?
Vir Biotechnology (NASDAQ:VIR) Shares Gap Up - Still a Buy...
MarketBeat·9d ago
News Placeholder
Insider Selling: Vir Biotechnology (NASDAQ:VIR) Major Shareholder Sells 191,854 Shares of Stock
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) major shareholder Endurance (Cayman) Ltd Svf sold 191,854 shares of the business's stock in a transaction that occurred on Monday, December 1st...
MarketBeat·13d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 191,854 Shares
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) major shareholder Endurance (Cayman) Ltd Svf sold 191,854 shares of the firm's stock in a transaction on Monday, December 1st. The shares were...
MarketBeat·13d ago
News Placeholder
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Recommendation of "Moderate Buy" by Analysts
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) has been given an average rating of "Moderate Buy" by the eleven analysts that are currently covering the stock, MarketBeat.com reports. One...
MarketBeat·13d ago
News Placeholder
Insider Selling: Vir Biotechnology (NASDAQ:VIR) Director Sells 22,000 Shares of Stock
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) Director Vicki Sato sold 22,000 shares of Vir Biotechnology stock in a transaction that occurred on Monday, December 1st. The shares were sold...
MarketBeat·14d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Shares Down 7.1% - What's Next?
Vir Biotechnology (NASDAQ:VIR) Trading Down 7.1% - Here's Why...
MarketBeat·15d ago
News Placeholder
Ensign Peak Advisors Inc Increases Position in Vir Biotechnology, Inc. $VIR
Ensign Peak Advisors Inc boosted its position in Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) by 812.7% during the second quarter, according to the company in its most recent Form 13F filing...
MarketBeat·19d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 235,971 Shares
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) major shareholder Endurance (Cayman) Ltd Svf sold 235,971 shares of the business's stock in a transaction that occurred on Tuesday, November...
MarketBeat·20d ago
<
1
2
...
>

Latest VIR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.